Myocardial ischemia-reperfusion injury and the influence of inflammation
Trends in Cardiovascular Medicine · 2023-08 · 33 (6) · 357-366
DOI: 10.1016/j.tcm.2022.02.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cardiovascular Medicine, 2023-08. Verfasst von Michiel Algoet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: michiel.algoet@kuleuven.be. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocardial Infarction, Myocardial Ischemia. Die Arbeit wurde bisher 540-mal zitiert (Crossref) und nennt 108 Literaturangaben. Gefördert von: KU Leuven.
Abstract (Originalsprache)
Acute myocardial infarction is caused by a sudden coronary artery occlusion and leads to ischemia in the corresponding myocardial territory which generally results in myocardial necrosis. Without restoration of coronary perfusion, myocardial scar formation will cause adverse remodelling of the myocardium and heart failure. Successful introduction of percutaneous coronary intervention and surgical coronary artery bypass grafting made it possible to achieve early revascularisation/reperfusion, hence limiting the ischemic zone of myocardium. However, reperfusion by itself paradoxically triggers an exacerbated and accelerated injury in the myocardium, called ischemia-reperfusion (I/R) injury. This mechanism is partially driven by inflammation through multiple interacting pathways. In this review we summarize the current insights in mechanisms of I/R injury and the influence of altered inflammation. Multiple pharmacological and interventional therapeutic strategies (ischemic conditioning) have proven to be beneficial during I/R in preclinical models but were notoriously unsuccessful upon clinical translation. In this review we focus on common mechanisms of I/R injury, altered inflammation and potential therapeutic strategies. We hypothesize that a dual approach may be of value because I/R injury patients are predestined with multiple comorbidities and systemic low-grade inflammation, which requires targeted intervention before other strategies can be fully effective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address: michiel.algoet@kuleuven.be.
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
- Biomedical MRI, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Helen B. Taussig Heart Center, The Johns Hopkins Hospital and School of Medicine, Baltimore, United States.
Förderung
- KU Leuven
Zitieren
APA
Algoet, M., Janssens, S., Himmelreich, U., Gsell, W., Pusovnik, M., Van den Eynde, J., & Oosterlinck, W. (2023). Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends in Cardiovascular Medicine, 33(6), 357-366. https://doi.org/10.1016/j.tcm.2022.02.005
Vancouver
Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends in Cardiovascular Medicine. 2023;33(6):357-366. doi:10.1016/j.tcm.2022.02.005
BibTeX
@article{Algoet2023,
author = {Algoet, Michiel and Janssens, Stefan and Himmelreich, Uwe and Gsell, Willy and Pusovnik, Matic and Van den Eynde, Jef and Oosterlinck, Wouter},
title = {Myocardial ischemia-reperfusion injury and the influence of inflammation},
journal = {Trends in Cardiovascular Medicine},
year = {2023},
volume = {33},
number = {6},
pages = {357--366},
doi = {10.1016/j.tcm.2022.02.005}
}
EUVIMED